Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission

Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion

(2010) Alan L. Pehrson et al.   PSYCHOPHARMACOLOGY

Group II metabotropic glutamate receptors and schizophrenia

(2009) José L. Moreno et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity

(2009) Chantal Schlumberger et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Methamphetamine- and 3,4-Methylenedioxymethamphetamine–Induced Behavioral Changes in Histamine H3–Receptor Knockout Mice

(2009) Tomohiro Okuda et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants

(2009) Jason M. Uslaner et al.   PSYCHOPHARMACOLOGY

Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)

(2008) M. J. Fell et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity

(2008) Yukio Ago et al.   SYNAPSE